Loxo Oncology at Lilly (United States)
ORCID: 0000-0001-5391-5691Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Driven by 8 papers. Top paper: “Mutant-selective degradation by BRAF-targeting PROTACs”.
Saul Jaime‐Figueroa, Zhan Yao, Yijun Gao, John Hines, Kusal T. G. Samarasinghe +4 more
Brooke E. Sylvester, Matthew T. Chang, Arijh Elzein, Jianjiong Gao, Weiwei Han +24 more
Christine A. Pratilas, Alexis M. Jones, Ricardo Ramirez, Helen Won, Cailian Liu +14 more
Radha Mukherjee, Rona Yaeger, Jieun Son, Jianing Xu, Na Na +22 more
Brooke E. Sylvester, Helen Won, Gregory McDermott, Deborah DeLair, Ricardo Ramirez +20 more
Dinesh Kumar, Tessa Seale, Santiago Garcia Borrego, Esther Kaplun, Ilinca Aricescu +17 more
Saul Jaime‐Figueroa, Zhan Yao, Yijun Gao, John Hines, Kusal T. G. Samarasinghe +4 more
Kai Pollard, Amy N. Allen, Tushar Tomar, Dirk Pijnenburg, Zhan Yao +3 more